The Cutting Edge of Medical Technology Content, Community & Collaboration
Sensor-Augmented Insulin Pump Therapy Achieves Better Glucose Control Than Daily Insulin Injections in People with Diabetes
Colleagues,
.... In the longest and largest randomized, controlled study of
sensor-augmented insulin pump therapy in type 1 diabetes, adult and
pediatric patients using the Medtronic MiniMed Paradigm® REAL-Time
System achieved better glucose control without an increase in
hypoglycemia compared to multiple daily insulin injections (MDI), the
most common approach to care today...
... The data also showed a statistically significant reduction in glycated hemoglobin (A1c) levels, which was
sustained over a prolonged one-year period for patients enrolled in the
sensor-augmented insulin pump therapy arm of the trial. Study results
were simultaneously published online in The New England Journal of
Medicine (NEJM) and presented at a late-breaking clinical study
symposium at the American Diabetes Association (ADA) 70th Scientific
Sessions in Orlando...
CC
.... In the longest and largest randomized, controlled study of
sensor-augmented insulin pump therapy in type 1 diabetes, adult and
pediatric patients using the Medtronic MiniMed Paradigm® REAL-Time
System achieved better glucose control without an increase in
hypoglycemia compared to multiple daily insulin injections (MDI), the
most common approach to care today...
... The data also showed a statistically significant reduction in glycated hemoglobin (A1c) levels, which was
sustained over a prolonged one-year period for patients enrolled in the
sensor-augmented insulin pump therapy arm of the trial. Study results
were simultaneously published online in The New England Journal of
Medicine (NEJM) and presented at a late-breaking clinical study
symposium at the American Diabetes Association (ADA) 70th Scientific
Sessions in Orlando...
CC
Views: 10
MedTechIQ VideoLibrary
Upcoming Events
© 2025 Created by CC-Conrad Clyburn-MedForeSight.
Powered by
